Jacobs Levy Equity Management’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-10,312
| Closed | -$29K | – | 1204 |
|
|
2020
Q1 | $29K | Buy |
+10,312
| New | +$29K | ﹤0.01% | 989 |
|
|
2018
Q1 | – | Sell |
-52,800
| Closed | -$145K | – | 1128 |
|
|
2017
Q4 | $145K | Sell |
52,800
-200
| -0.4% | -$549 | ﹤0.01% | 933 |
|
|
2017
Q3 | $180K | Buy |
+53,000
| New | +$180K | ﹤0.01% | 880 |
|
|
2016
Q3 | – | Sell |
-836,862
| Closed | -$2.63M | – | 1251 |
|
|
2016
Q2 | $2.63M | Sell |
836,862
-427,817
| -34% | -$1.34M | 0.05% | 371 |
|
|
2016
Q1 | $4.21M | Buy |
+1,264,679
| New | +$4.21M | 0.09% | 250 |
|
|
2015
Q3 | – | Sell |
-10,800
| Closed | -$69K | – | 930 |
|
|
2015
Q2 | $69K | Hold |
10,800
| – | – | ﹤0.01% | 777 |
|
|
2015
Q1 | $76K | Buy |
+10,800
| New | +$76K | ﹤0.01% | 754 |
|
|
2013
Q4 | – | Sell |
-75,900
| Closed | -$605K | – | 1135 |
|
|
2013
Q3 | $605K | Buy |
+75,900
| New | +$605K | 0.01% | 643 |
|